Is OxyContin still sold?
Purdue ceased to exist on May 1, 2026, when its assets passed to Knoa Pharma — an independent foundation focused on opioid-treatment medicines with no profit obligation. Oxycodone itself remains a widely used and legitimate medicine for severe pain.
Purdue Pharma ceased to exist when its bankruptcy plan took effect on May 1, 2026, and its assets passed to Knoa Pharma, a company owned by an independent foundation. Knoa is focused on providing opioid use disorder treatments and overdose reversal medicines, with no obligation to maximise profits, and operates under a strict injunction supervised by a monitor to ensure it sells its products safely. Oxycodone itself remains a legitimate and widely used medicine for severe pain, and extended-release opioids continue to be prescribed. The legacy of OxyContin is visible in today's tighter prescribing guidelines, prescription monitoring programmes and restrictions on opioid marketing, as well as the continuing illicit fentanyl crisis that followed.